TRCT
GILD icon

Tower Research Capital (TRC)’s Gilead Sciences GILD Stock Holding History

Tower Research Capital (TRC)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.38M Sell
52,946
-33,540
-39% -$4.7M 0.19% 93
2025
Q4 		$10.6M Buy
86,486
+40,162
+87% +$4.88M 0.26% 65
2025
Q3 		$5.14M Sell
46,324
-1,476
-3% -$168K 0.14% 119
2025
Q2 		$5.3M Buy
47,800
+18,390
+63% +$1.96M 0.14% 118
2025
Q1 		$3.24M Sell
29,410
-79,873
-73% -$8.24M 0.1% 169
2024
Q4 		$10.1M Buy
109,283
+70,872
+185% +$6.38M 0.2% 76
2024
Q3 		$3.22M Sell
38,411
-84,379
-69% -$6.44M 0.09% 169
2024
Q2 		$8.42M Sell
122,790
-63,710
-34% -$4.25M 0.14% 107
2024
Q1 		$13.7M Sell
186,500
-14,560
-7% -$1.12M 0.33% 48
2023
Q4 		$16.3M Buy
201,060
+135,782
+208% +$10.6M 0.2% 87
2023
Q3 		$4.89M Buy
65,278
+41,632
+176% +$3.2M 0.15% 111
2023
Q2 		$1.82M Buy
23,646
+3,035
+15% +$242K 0.06% 255
2023
Q1 		$1.71M Sell
20,611
-23,782
-54% -$1.97M 0.05% 235
2022
Q4 		$3.81M Sell
44,393
-233,549
-84% -$18.5M 0.16% 80
2022
Q3 		$17.1M Buy
277,942
+67,593
+32% +$4.26M 0.28% 59
2022
Q2 		$13M Sell
210,349
-173,719
-45% -$10.8M 0.29% 57
2022
Q1 		$22.8M Buy
384,068
+245,623
+177% +$15.7M 0.22% 87
2021
Q4 		$10.1M Buy
138,445
+419
+0.3% +$28.9K 0.17% 94
2021
Q3 		$9.64M Buy
138,026
+88,752
+180% +$6.24M 0.25% 56
2021
Q2 		$3.39M Sell
49,274
-158,898
-76% -$10.6M 0.09% 164
2021
Q1 		$13.5M Buy
208,172
+136,093
+189% +$8.78M 0.23% 77
2020
Q4 		$4.2M Buy
72,079
+15,627
+28% +$943K 0.13% 94
2020
Q3 		$3.57M Buy
56,452
+25,952
+85% +$1.8M 0.04% 145
2020
Q2 		$2.35M Buy
+30,500
New +$2.34M 0.1% 182
2020
Q1 		– Sell
-2,460
Closed -$160K – 3353
2019
Q4 		$160K Sell
2,460
-13,978
-85% -$910K 0.01% 688
2019
Q3 		$1.04M Sell
16,438
-28,472
-63% -$1.86M 0.07% 275
2019
Q2 		$3.03M Buy
44,910
+27,477
+158% +$1.81M 0.2% 65
2019
Q1 		$1.13M Buy
17,433
+17,311
+14,189% +$1.15M 0.07% 241
2018
Q4 		$8K Sell
122
-2,529
-95% -$177K ﹤0.01% 2615
2018
Q3 		$205K Sell
2,651
-64,360
-96% -$4.86M 0.02% 957
2018
Q2 		$4.75M Buy
67,011
+66,747
+25,283% +$4.71M 0.27% 67
2018
Q1 		$20K Sell
264
-8,445
-97% -$671K ﹤0.01% 2169
2017
Q4 		$624K Buy
8,709
+3,845
+79% +$292K 0.08% 250
2017
Q3 		$394K Buy
+4,864
New +$372K 0.03% 344
2017
Q1 		– Sell
-12,204
Closed -$874K – 3370
2016
Q4 		$874K Buy
+12,204
New +$907K 0.09% 227
2016
Q2 		– Sell
-26,938
Closed -$2.48M – 4620
2016
Q1 		$2.48M Buy
26,938
+26,889
+54,876% +$2.42M 0.37% 46
2015
Q4 		$5K Buy
+49
New +$5.1K ﹤0.01% 2972
2015
Q3 		– Sell
-696
Closed -$81K – 4284
2015
Q2 		$81K Buy
696
+534
+330% +$58.4K 0.01% 1007
2015
Q1 		$16K Buy
162
+160
+8,000% +$16.2K ﹤0.01% 2426
2014
Q4 		$0 Sell
2
-42,417
-100% -$4.39M ﹤0.01% 4244
2014
Q3 		$4.51M Buy
42,419
+39,397
+1,304% +$3.86M 0.51% 26
2014
Q2 		$251K Buy
3,022
+960
+47% +$74.7K 0.03% 512
2014
Q1 		$146K Sell
2,062
-1,034
-33% -$81.1K 0.02% 522
2013
Q4 		$233K Sell
3,096
-59,154
-95% -$4.12M 0.04% 446
2013
Q3 		$3.91M Buy
62,250
+62,154
+64,744% +$3.71M 0.42% 45
2013
Q2 		$5K Buy
+96
New +$5K ﹤0.01% 2928

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tower Research Capital (TRC)'s GILD Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Gilead Sciences (GILD) stake by 39% in Q1 2026, selling an estimated $4.7M and leaving 52,946 shares worth $7.38M. The position accounts for 0.19% of the portfolio, ranked #93.

Tower Research Capital (TRC) first reported a position in GILD in Q2 2013 and has held it in 46 quarters since. The position peaked at $22.8M in Q1 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Tower Research Capital (TRC) held 52,946 shares of Gilead Sciences worth $7.38M as of Q1 2026.
  • Tower Research Capital (TRC) sold 33,540 Gilead Sciences shares in Q1 2026, an estimated $4.7M.
  • Gilead Sciences made up 0.19% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #93 holding.
  • Tower Research Capital (TRC) first reported a position in Gilead Sciences in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s Gilead Sciences position peaked at $22.8M in Q1 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.